Xtandi 40 mg Oral Tablet
RxNorm 2390646
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2390646 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Xtandi 40 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Enzalutamide 40 mg Oral Tablet [Xtandi]
(Atom ID: 12425757)
PSNPrescribable
Prescribable Name (PSN):
Xtandi 40 mg Oral Tablet
(Atom ID: 12425759)
SYPrescribable
Synonym (SY):
Xtandi 40 mg Oral Tablet
(Atom ID: 12425758)
Patient Education
Enzalutamide
Enzalutamide is used to treat prostate cancer that has spread to other parts of the body in men and who have been helped by certain medical and surgical treatments that decrease testosterone levels. It is also used to treat prostate cancer in men who have not been helped by certain medical and surgical treatments that decrease testosterone levels. Enzalutamide is in a class of medications called androgen receptor inhibitors. It works by blocking the effects of androgen (a male reproductive hormone) to stop the growth and spread of cancer cells.
[Learn More]
* Please review the disclaimer below.